Biochemical and Physiological Response to Stressogenic Stimuli

Sponsor
Nadav Goldental (Other)
Overall Status
Unknown status
CT.gov ID
NCT04076215
Collaborator
(none)
50
2
9

Study Details

Study Description

Brief Summary

Post-traumatic stress disorder (PTSD) is characterized by physiological changes, some of which are thought to be chronic, while others are observed in response to stressogenic stimuli. A psychiatric diagnosis of PTSD is currently based mainly on non-quantitative elements, such as interviews and subjective impressions. Discernable patterns of stress-related measures may constitute a physiological and biochemical phenotype characteristic of PTSD, which may serve as a biomarker and support diagnostic decisions, as well as personalized treatment plans.

The current study is aimed at examining the possibility of basing a psychiatric diagnosis by measuring changes in the biochemical phenotype of participants with PTSD. Physiological and biochemical data will be collected from participants with and without PTSD using wearable sensors and adhesive biosensor patches. The data will be collected in two conditions: in a neutral, quiet situation, and during and following exposure to controlled stressogenic stimuli.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Stressogenic stimulus
  • Device: Biobeat smart watch and adhesive biosensor patches.
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Measuring the Biochemical and Physiological Response to Controlled Stressogenic Stimuli
Anticipated Study Start Date :
Sep 1, 2019
Anticipated Primary Completion Date :
Feb 1, 2020
Anticipated Study Completion Date :
Jun 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Pariticapnts with PTSD

Behavioral: Stressogenic stimulus
Participants will be exposed to an anxiety-provoking stimulus for 15-20 minutes, in a controlled setting

Device: Biobeat smart watch and adhesive biosensor patches.
Physiological and biochemical measures will be obtained using the Biobeat smart watch and adhesive biosensor patches.

Experimental: Pariticapnts without PTSD (controls)

Behavioral: Stressogenic stimulus
Participants will be exposed to an anxiety-provoking stimulus for 15-20 minutes, in a controlled setting

Device: Biobeat smart watch and adhesive biosensor patches.
Physiological and biochemical measures will be obtained using the Biobeat smart watch and adhesive biosensor patches.

Outcome Measures

Primary Outcome Measures

  1. Significant differences between groups - HRV [3 hours]

    Significant differences in Heart Rate Variability - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  2. Significant differences in physiological changes between groups - temperature [3 hours]

    Significant differences in physiological changes - body temperature- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  3. Significant differences in physiological changes between groups - SPO2 [3 hours]

    Significant differences in physiological changes - Saturation SPO2- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  4. Significant differences in physiological changes between groups - blood pressure [3 hours]

    Significant differences in physiological changes - continuous blood pressure- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  5. Significant differences in physiological changes between groups - pulse pressure [3 hours]

    Significant differences in physiological changes - pulse pressure - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  6. Significant differences in physiological changes between groups -respiratory rate [3 hours]

    Significant differences in physiological changes - respiratory rate- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  7. Significant differences in physiological changes between groups -stroke volume [3 hours]

    Significant differences in physiological changes - stroke volume- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  8. Significant differences in physiological changes between groups -cardiac output [3 hours]

    Significant differences in physiological changes - cardiac output - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  9. Significant differences in physiological changes between groups - systemic vascular resistance [3 hours]

    Significant differences in physiological changes - systemic vascular resistance- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  10. Significant differences in cortisol levels between groups [3 hours]

    Significant differences in biochemical changes - cortisol - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  11. Significant differences in biochemical changes between groups - C-reactive protein [3 hours]

    Significant differences in biochemical changes - C-reactive protein - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  12. Significant differences in biochemical changes between groups - Interleukin 6 [3 hours]

    Significant differences in biochemical changes - Interleukin 6 - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  13. Significant differences in biochemical changes between groups - N-terminal B-type natriuretic peptide [3 hours]

    Significant differences in biochemical changes - N-terminal B-type natriuretic peptide - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  14. Significant differences in biochemical changes between groups - 8-oxo-7 [3 hours]

    Significant differences in biochemical changes - 8-oxo-7- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  15. Significant differences in biochemical changes between groups - 8-dihydro-2'-deoxyguanosine [3 hours]

    Significant differences in biochemical changes - 8-dihydro-2'-deoxyguanosine - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  16. Significant differences in biochemical changes between groups - hexanone [3 hours]

    Significant differences in biochemical changes - hexanone - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  17. Significant differences in biochemical changes between groups - acetic acid [3 hours]

    Significant differences in biochemical changes - acetic acid - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  18. Significant differences in biochemical changes between groups - heptane [3 hours]

    Significant differences in biochemical changes - heptane - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  19. Significant differences in biochemical changes between groups - hexanal [3 hours]

    Significant differences in biochemical changes -hexanal - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  20. Significant differences in biochemical changes between groups - 3-heptanone [3 hours]

    Significant differences in biochemical changes - 3-heptanone - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  21. Significant differences in biochemical changes between groups - hexanoic acid [3 hours]

    Significant differences in biochemical changes - hexanoic acid - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  22. Significant differences in biochemical changes between groups - heptanal [3 hours]

    Significant differences in biochemical changes -heptanal - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  23. Significant differences in biochemical changes between groups - nonanal [3 hours]

    Significant differences in biochemical changes - nonanal - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

  24. Significant differences in biochemical changes between groups - glucose [3 hours]

    Significant differences in biochemical changes - glucose - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • PTSD diagnosis (excluding controls)

  • Proper ability to give informed consent

Exclusion Criteria:
  • Active oncological/cardiovascular condition

  • Dialysis patients

  • Active psychotic or suicidal symptoms

  • Severe dissociative symptoms

  • A traumatic brain injury (TBI) diagnosis

  • Pregnancy

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Nadav Goldental

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nadav Goldental, Principal investigator, The Chaim Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT04076215
Other Study ID Numbers:
  • 6263-19-SMC
First Posted:
Sep 3, 2019
Last Update Posted:
Sep 3, 2019
Last Verified:
Aug 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 3, 2019